Table 3.

Baseline hematology and coagulation profiles of patients receiving platelet transfusions for thrombocytopenia

Treatment group
Test, n = 52Reference, n = 51
No.3-150ValueNo.3-150Value
Hematocrit, %, mean ± SD 47 0.27 ± 0.05 50 0.26 ± 0.05 
Platelet count, mean ± SD, × 109/L 52 19.1 ± 13.3 51 16.7 ± 13.1 
Hemoglobin level, mean ± SD, g/L 51 94.4 ± 15.8 48 89.0 ± 19.1  
Fibrinogen level, mean ± SD, g/L 47 4.673 ± 1.647 44 4.724 ± 1.203  
White blood cell count, median3-151, × 109/L 52 0.350 51 0.220 
Prothrombin time, mean ± SD, sec 28 12.8 ± 4.1 26 12.1 ± 1.8  
Partial thromboplastin time, mean ± SD, sec 50 35.0 ± 9.2 46 34.7 ± 9.2 
Treatment group
Test, n = 52Reference, n = 51
No.3-150ValueNo.3-150Value
Hematocrit, %, mean ± SD 47 0.27 ± 0.05 50 0.26 ± 0.05 
Platelet count, mean ± SD, × 109/L 52 19.1 ± 13.3 51 16.7 ± 13.1 
Hemoglobin level, mean ± SD, g/L 51 94.4 ± 15.8 48 89.0 ± 19.1  
Fibrinogen level, mean ± SD, g/L 47 4.673 ± 1.647 44 4.724 ± 1.203  
White blood cell count, median3-151, × 109/L 52 0.350 51 0.220 
Prothrombin time, mean ± SD, sec 28 12.8 ± 4.1 26 12.1 ± 1.8  
Partial thromboplastin time, mean ± SD, sec 50 35.0 ± 9.2 46 34.7 ± 9.2 

There were no statistical differences between groups(P > .05).

F3-150

Number of patients with baseline values.

F3-151

The median is given, rather than the mean, owing to a nonnormal distribution of values.

or Create an Account

Close Modal
Close Modal